Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as the new president

- Reorganizing the global sales networks and enhancing its capabilities to get global approvals for new drug - Accelerating value of the new drug pipelines SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- DxVx announced on the 16th, the board of directors appointedYong Gu Lee as the new CEO and ...

2023-05-16 21:00 2480

DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as the new president

NCCN Global Policy Leader Named Co-Chair of Global Health Council Roundtable Advancing International Coordination in Cancer Care

Katy Winckworth-Prejsnar, Senior Manager of Global Policy and Strategic Alliances for National Comprehensive Cancer Network, to Co-Chair Non-Communicable Diseases Roundtable PLYMOUTH MEETING, Pa., May 16, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the...

2023-05-16 20:37 1828

NCCN Global Policy Leader Named Co-Chair of Global Health Council Roundtable Advancing International Coordination in Cancer Care

Omega Healthcare Achieves HITRUST Implemented, 1-year Certification to Manage Cybersecurity Risk and Improve Information Security Posture

HITRUST Implemented, 1-year (i1) Certification validates Omega Healthcare is operating leading security practices to support the protection of sensitive information BOCA RATON, Fla., May 16, 2023 /PRNewswire/ -- Omega Healthcare, a leading healthcare management solutions partner supporting the b...

2023-05-16 20:00 1731

MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment of Dr.Ste...

2023-05-16 19:00 2079

YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan

GAITHERSBURG, Md., May 16, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious d...

2023-05-16 19:00 1970

Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts

EAST RUTHERFORD, N.J., May 16, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that Snapdragon Chemistry has completed the se...

2023-05-16 18:00 2202

WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients

* WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. * InflaRx received emergency use authorization (EUA) from the FDA for Gohibic (vilobelimab) for the treatment of certain critically ill COVID-19 patients in April ...

2023-05-16 16:00 1807

LG Chem Targets Sixfold Sales Growth in Battery Materials to KRW 30 Trillion by 2030

- Will expand sales portion in battery materials, sustainability business and innovative new drugs - Aims to accelerate in reaching net zero by 2050 by proactively building an integrated low-carbon management system SEOUL, South Korea, May 15, 2023 /PRNewswire/ -- LG Chem today announced i...

2023-05-16 09:34 2464

Medit continues to see strong scanner adoption in Q1 2023

* Medit intraoral scanner installation is growing at almost 50% vs PY * Medit Link serves as a key differentiator that has the potential to become the cornerstone of digital dentistry SEOUL, South Korea and LONG BEACH, Calif., May 16, 2023 /PRNewswire/ -- Medit (www.medit.com

2023-05-16 08:00 3172

Medit continues to see strong scanner adoption in Q1 2023

LYNK's LNK01001 Achieved Exciting Phase II Results in Rheumatoid Arthritis

HANGZHOU, China, May 16, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that the Phase II clinical trial of LNK01001 in the treatment of rheumatoid arthritis (RA) showed statistically signifi...

2023-05-16 08:00 3734

BPAC and Novari Health Announce eReferral Integration

SYDNEY, Australia, May 16, 2023 /PRNewswire/ -- Novari Health and BPAC Clinical Solutions are proud to announce the successful integration of Novari's referral management software with BPAC's secure electronic referral system. This integration will provide an enhanced, streamlined, and more effic...

2023-05-16 06:00 1886

BPAC and Novari Health Announce eReferral Integration

China International Medical Equipment Fair 2023 Held in Shanghai in May, Showcasing Cutting-Edge Healthcare Technologies

SHANGHAI, May 15, 2023 /PRNewswire/ -- The 87th edition of the China International Medical Equipment Fair (CMEF) has opened its door to the world in Shanghai. Hosted from May 14 – 17th, the show once again brought together the latest and the great solutions created to drive innovations and push th...

2023-05-15 22:56 3130

China International Medical Equipment Fair 2023 Held in Shanghai in May, Showcasing Cutting-Edge Healthcare Technologies

Patient Enrollment Completed for Phase III Clinical Trial of Boan Biotech's Dulaglutide Injection BA5101 in China

YANTAI, China, May 15, 2023 /PRNewswire/ -- Boan Biotech today announced the completion of patient enrollment for the Phase III clinical trial (a comparative clinical study of efficacy and safety) of the company's Dulaglutide Injection (BA5101) inChina. BA5101 is a biosimilar of Trulicity®, used...

2023-05-15 21:58 3844

CMUH Smart Medicine System Assisted the ARDS Specialist Team Successfully Reversed the Patient's Critical Condition

TAICHUNG,Taiwan, May 15, 2023 /PRNewswire/ -- After the worldwide COVID-19 pandemic, most people suffered from mild disease, and "Acute Respiratory Distress Syndrome (ARDS)" is common for those critical COVID-19 patients. The 46-year-old of Ms. Chang, who had hypertension and nephropathy, accepte...

2023-05-15 20:30 1516

CMUH Smart Medicine System Assisted the ARDS Specialist Team Successfully Reversed the Patient's Critical Condition

ChomiX Biotech Announces millions of dollars Series Pre-A+ Financing to accelerate the development of Chemoproteomics Platform

NANJING, China, May 15, 2023 /PRNewswire/ -- Recently, ChomiX Biotech Co., Ltd. (hereinafter referred to as ChomiX), a leading biotechnology company focusing on the preclinical development of innovative small molecule drugs, announced the completion of millions of dollars Pre-A+ Financing by Tige...

2023-05-15 20:00 1643

Treasure Global Announces Strategic Brand Partnership For Zstore Affiliate Program Enhancing Its Health and Wellness E-Commerce Solution

- Zstore Named Sole Marketing And Selling Platform Of enogy Brand Health and Wellness Products - NEW YORK AND KUALA LUMPUR, Malaysia, May 15, 2023 /PRNewswire/ -- Treasure Global Inc (NASDAQ: TGL) ("Treasure Global," or the "Company"), an innovative technology solutions provider for the F&B ind...

2023-05-15 20:00 2789

Meihua International Medical Technologies Co., Ltd.'s Subsidiary to Attend and Showcase 12 New Products at the 87th China International Medical Equipment Fair

YANGZHOU, China, May 15, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced that its wholly...

2023-05-15 19:30 1771

Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F for Treatment of Refractory Systemic Lupus Erythematosus (SLE)

Gracell announces start of investigator-initiated trial to expand clinical evaluation of FasTCAR-T GC012F into autoimmune disease GC012F pioneers the use of CD19/BCMA dual-targeting CAR-T in SLE, aiming for deeper and wider depletion of autoantibodies producing B-cells and plasma cells SAN DIEGO...

2023-05-15 19:00 1733

Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma

* Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 mAb, in combination with cetuximab, an anti-EGFR mAb, in sqNSCLC * HMBD-001 used as monotherapy and in combination with cetuximab has been ...

2023-05-15 18:30 2174

Boosting health equity in the world of climate change

* Between 2030 and 2050, climate change is expected to cause approximately 250 000 additional deaths per year from malnutrition, malaria, diarrhoea and heat stress alone - WHO * Join 200 policy and topic leaders to explore the health risks and impacts of climate change on healthcare SINGAPORE...

2023-05-15 17:59 2118

Boosting health equity in the world of climate change

1 ... 156 157 158159160 161 162 ... 808